Syndax Pharmaceuticals (SNDX) Change in Cash (2015 - 2026)

Syndax Pharmaceuticals' Change in Cash history runs 12 years deep, the most recent figure standing at -$4.0 million for Q1 2026.

• In Q1 2026, Change in Cash fell 4385.56% year-over-year to -$4.0 million; the TTM figure through Mar 2026 stood at -$23.2 million (down 158.95% YoY), while the FY2025 annual figure was -$19.3 million, up 86.36% from the prior year.
• Change in Cash was -$4.0 million for Q1 2026 at Syndax Pharmaceuticals, down from $18.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $200.8 million in Q4 2023 to a low of -$180.8 million in Q1 2024.
• Historically, Change in Cash has averaged -$5.4 million across 5 years, with a median of -$2.7 million in 2023.
• The sharpest annual moves came in 2023 and 2026: Change in Cash surged 6641.99% in 2023, then plunged 4385.56% in 2026.
• A 5-year view of Change in Cash shows it stood at $3.0 million in 2022, then soared by 6641.99% to $200.8 million in 2023, then plunged by 89.51% to $21.1 million in 2024, then fell by 14.51% to $18.0 million in 2025, then plunged by 122.42% to -$4.0 million in 2026.
• The last three Change in Cash figures came in at -$4.0 million (Q1 2026), $18.0 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.